Management of Facial Linear Epidermal Nevus in Fitzpatrick Type VI Skin

First‑Line Treatment: Microneedling with Autologous Platelet Concentrates (APCs)

Microneedling combined with autologous platelet concentrates is recommended as the optimal first‑line therapy for facial linear epidermal nevus in patients with the darkest skin type because it carries a minimal risk of post‑inflammatory hyperpigmentation (PIH) and scarring compared with laser modalities. 1
The procedure uses adjustable needle depths ranging from 0.25 mm to 2.5 mm to create micro‑channels that are subsequently filled with autologous growth factors, promoting tissue remodeling without the thermal injury associated with energy‑based devices. 1
Typical downtime after microneedling with APCs is only 24–48 hours, making the approach practical for facial lesions. 1
Prior to microneedling, a compounded topical anesthetic should be applied for at least 30 minutes and thoroughly removed before treatment begins. 1
During microneedling, adequate lubrication with APCs is essential to avoid a dry‑tugging sensation that could increase trauma. 1
Microneedling should not be performed over areas with active inflammation or infection. 1
For facial lesions, needle depths of approximately 0.5–1.5 mm are typically used, adjusted according to lesion location. 1

Individuals with Fitzpatrick type VI skin exhibit the most pronounced delayed tanning responses and pigmentary complications of any skin type; careful monitoring for mottled hypo‑ and hyperpigmentation is required. 2
Treatment intervals of at least 48–72 hours between microneedling sessions are advised to allow assessment for adverse pigmentary reactions before the next session. [2][3]

A daily broad‑spectrum sunscreen with a minimum SPF 30 must be applied to all exposed areas, with re‑application every 2 hours during sun exposure. [2][4]
Physical barriers such as wide‑brimmed hats and protective clothing are mandatory adjunctive measures to minimize UV‑induced pigmentary changes. [2][4]
Patients should avoid direct sunlight and heavily scented facial products for 24 hours after the procedure. 1
Follow‑up monitoring for delayed erythema and pigmentary changes should be performed at 24–48 hours and again at 4 weeks post‑treatment. 3

Intense pulsed light (IPL) and broad‑spectrum light devices are absolutely contraindicated in Fitzpatrick type VI patients because the high melanin content absorbs excessive light energy, leading to burns and severe pigmentation changes. [3][4]
If a laser is considered despite the risks, fluences must be dramatically reduced; for example, CO₂ laser settings should not exceed 25–40 J/cm² with a 20‑ms pulse duration. 3
Standard laser settings designed for lighter skin (e.g., 35–50 J/cm² with 10‑ms pulse duration) are contraindicated and can cause severe complications in type VI skin. 4
Ablative modalities—including CO₂ laser, Q‑switched lasers at standard fluences, and any high‑energy ablative devices—should be avoided entirely. [3][4]

First‑line: Microneedling with APCs using appropriate needle depth (0.5–1.5 mm for facial lesions). 1
If response is inadequate after 3–4 sessions: Consider adding a non‑ablative 1550 nm fractional laser at highly conservative settings with mandatory hydroquinone prophylaxis (not detailed here due to lack of cited evidence).
Key pitfalls to avoid:
- Using laser parameters intended for lighter skin types (e.g., 35–50 J/cm², 10‑ms) in type VI skin. 4
- Performing microneedling over inflamed or infected areas. 1
- Failing to provide adequate lubrication with APCs during microneedling. 1